FDA Approved: MEDROXYPROGESTERONE ACETATE — Supplemental Application (Prasco Laboratories)

View source ↗

Summary

The FDA approved a supplemental application for Medroxyprogesterone acetate from Prasco Laboratories, resulting in labeling changes associated with the approved…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Abnormal Uterine Bleeding
• Amenorrhea
• Dysmenorrhea
• Endometrial Cancer
• Endometrial Hyperplasia

Drugs mentioned

• Medroxyprogesterone acetate (Medroxyprogesterone acetate)

Snippet

SUPPL AP for MEDROXYPROGESTERONE ACETATE (MEDROXYPROGESTERONE ACETATE)